−60.9
Celldex Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−104
FY23:
−107
FY24:
−158
FY25:
−211
Change from FY21 to FY25
millions USD
FY21:
−216
FY22:
89.9
FY23:
−106
FY24:
−290
FY25:
209
Change from FY21 to FY25
millions USD
FY21:
272
FY22:
4.08
FY23:
218
FY24:
441
FY25:
2.39
millions USD
FY21:
−4.69
FY22:
−9.71
FY23:
5.39
FY24:
−6.46
FY25:
0.52
(positive)
Change from FY21 to FY25
millions USD
FY21:
−62.2
FY22:
−106
FY23:
−109
FY24:
−160
FY25:
−214
All amounts in millions USD